Tar Heel Times
Your comprehensive source for Tar Heel sports news

Quintiles, spin-off company from UNC, makes Fortune 500 list


Durham-based Quintiles has been named to the Fortune 500 list of the largest U.S. companies by revenue. The biopharmaceutical services company was No. 486 on the list. The company, whose major business is the contract management of clinical trials for drug development firms, brought in $5.099 billion in total revenues in 2013. (Durham Herald-Sun)


Share: Facebook | Twitter | Email

Related:

Recent Campus Connections News:

First Black Female FBI Agent was UNC-Chapel Hill Alumna

Dr. Martin Luther King, Jr.'s Visit to UNC in 1960: ‘In the presence of greatness’

UNC researchers use light to launch drugs from red blood cells

UNC awarded $19 million to study atherosclerosis risk in communities

Video: Dr. Oliver Smithies, in memoriam


© 2005-2017 Tar Heel Times | Contact | Privacy Policy | Site Map | RSS | Did UNC Win?

Tar Heel Times is an unofficial resource for UNC fans and is not affiliated with the University of North Carolina.